Two doses of COVID-19 vaccinations will not suffice to neutralize antibodies against the Omicron variant of the Coronavirus, found British scientists. They further found that those who have been previously infected or vaccinated may face increased infections. Researchers from the University… Read More ›
hospitalization
Merck & Co Inc and Ridgeback Biotherapeutics creates game changing COVID19 antiviral pill
Britain has become the first country in the world to approve a potential game-changing COVID-19 antiviral pill, which was jointly developed by US based Merck & Co Inc and Ridgeback Biotherapeutics, in its effort to fight the Wuhan Coronavirus. Britain’s Medicines… Read More ›